Kura Oncology, Inc. (NASDAQ:KURA) is held by 208 institutional investors per 13F filings through December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Mar, 2026 | 9,637,531 | 626,738 | 6.96% | $78,353,125.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 9,010,793 | -504,342 | -5.30% | $93,622,139.00 |
| BVF INC/IL | 31 Mar, 2026 | 8,617,162 | 0 | 0.00% | $89,532,313.00 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 8,575,422 | 0 | 0.00% | $69,718,181.00 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 8,575,422 | 459,422 | 5.66% | $89,098,635.00 |
| BVF INC/IL | 31 Mar, 2026 | 8,445,769 | -171,393 | -1.99% | $68,664,102.00 |
| VANGUARD GROUP INC | 31 Mar, 2026 | 5,507,627 | 39,105 | 0.72% | $57,224,245.00 |
| ARMISTICE CAPITAL, LLC | 31 Mar, 2026 | 4,936,000 | 264,000 | 5.65% | $51,285,040.00 |
| State Street Corp | 31 Mar, 2026 | 4,931,090 | 1,587,959 | 47.50% | $51,234,025.00 |
| State Street Corp | 31 Mar, 2026 | 4,511,891 | -419,199 | -8.50% | $36,681,674.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 3,785,685 | 3,785,685 | 0.00% | $30,777,619.00 |
| ARMISTICE CAPITAL, LLC | 31 Mar, 2026 | 3,736,000 | -1,200,000 | -24.31% | $30,373,680.00 |
| Goldman Sachs Group Inc | 31 Mar, 2026 | 3,674,528 | 1,059,802 | 40.53% | $38,178,346.00 |
| AQR CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 3,062,212 | 820,020 | 36.57% | $31,816,384.00 |
| Deep Track Capital, LP | 31 Mar, 2026 | 2,643,542 | 2,643,542 | 0.00% | $21,491,996.00 |
| Prosight Management, LP | 31 Mar, 2026 | 2,529,600 | -228,916 | -8.30% | $26,282,544.00 |
| AQR CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 2,124,480 | -937,732 | -30.62% | $17,272,026.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 2,034,276 | 5,658 | 0.28% | $16,542,370.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 2,028,618 | -19,308 | -0.94% | $21,081,811.00 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 31 Mar, 2026 | 2,022,333 | -202,257 | -9.09% | $21,012,040.00 |